These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The University of California at Los Angeles heart transplantation experience. Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A Clin Transpl; 2005; ():173-85. PubMed ID: 17424734 [TBL] [Abstract][Full Text] [Related]
5. Low-dose tacrolimus/sirolimus and steroid withdrawal in heart recipients is highly efficacious. Meiser B; Kaczmarek I; Mueller M; Groetzner J; Weis M; Knez A; Stempfle HU; Klauss V; Schmoeckel M; Reichart B; Ueberfuhr P J Heart Lung Transplant; 2007 Jun; 26(6):598-603. PubMed ID: 17543783 [TBL] [Abstract][Full Text] [Related]
6. Mannose-binding lectin deficiency offers protection from acute graft rejection after heart transplantation. Fildes JE; Shaw SM; Walker AH; McAlindon M; Williams SG; Keevil BG; Yonan N J Heart Lung Transplant; 2008 Dec; 27(12):1353-6. PubMed ID: 19059118 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation. Myre SA; Schroeder TJ; Melvin DB; Pesce AJ; Collins JA; Stephens GW; First MR Transplant Proc; 1989 Feb; 21(1 Pt 3):2484-6. PubMed ID: 2650310 [No Abstract] [Full Text] [Related]
8. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients. Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928 [TBL] [Abstract][Full Text] [Related]
9. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789 [TBL] [Abstract][Full Text] [Related]
10. [Renal function in the immediate postoperative period after heart transplantation using very low initial doses of cyclosporin A]. Cladellas M; Sánchez JM; Abadal ML; Ballester M; Obrador D; Amengual MJ; Quintana E; Net A; Cámara ML; Padró JM Rev Esp Cardiol; 1987; 40 Suppl 2():70-3. PubMed ID: 3331810 [No Abstract] [Full Text] [Related]
11. A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients. Schnetzler B; Leger P; Völp A; Dorent R; Pavie A; Gandjbakhch I Transpl Int; 2002 Jun; 15(6):317-25. PubMed ID: 12072903 [TBL] [Abstract][Full Text] [Related]
13. [Sudden death as the only manifestation of rejection in the heart transplant patient treated with cyclosporin A]. Abadal ML; Ballester M; Cladellas M; Obrador D; Badía F; Rodríguez C; Bordes R; García-Moll M; Padró J; Arís A Rev Esp Cardiol; 1987; 40 Suppl 2():52-4. PubMed ID: 3331806 [No Abstract] [Full Text] [Related]
14. Heart transplantation in Paris, at "La Pitie" Hospital. Cabrol C; Gandjbakhch I; Pavie A; Cabrol A; Mattei MF; Leger P J Heart Transplant; 1985; 4(5):476-80. PubMed ID: 3916522 [No Abstract] [Full Text] [Related]
15. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Luque J; Torres MI; Aumente MD; Marín J; García-Jurado G; González R; Pascual D; Guerra N; López-Rubio F; Alvarez-López MR; Arizón JM; Peña J Hum Immunol; 2006; 67(4-5):257-63. PubMed ID: 16720205 [TBL] [Abstract][Full Text] [Related]